Don’t miss out - Get your tickets early!

Join this FREE, 75-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

Join this FREE WEBINAR presented by Dr Ronald D. Siegel (USA)

Over the past 15 years mindfulness and compassion practices have become part of mainstream psychotherapy, while more recently research on psychedelic-assisted psychotherapy has mushroomed, offering not only possible breakthrough treatments for PTSD, depression, addictions, and end-of-life anxiety, but providing new insights into the nature of psychological distress and mechanisms of healing.

How can these developments inform our clinical practice if we’re not participating in the research? In this presentation, we’ll explore the common healing factors in non-ordinary states as well as practical applications of these in all forms of therapy.

Topic: Learning from Non-Ordinary States: Mindfulness, Compassion, & Psychedelics

Date: Wednesday 7 September 2022

Time: 12:55am for 1:00pm start – 2:15pm (incl Q&A) (AEST)

The presentation WILL BEGIN AT 1:00pm.

Location: Online. A link will be emailed to you with the viewing details

Don’t miss out - Get your tickets early!

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

More about the presenters

Dr Ronald D. Siegel (USA)

Assistant Professor of Psychology, Harvard Medical School, USA

Dr. Siegel is a long-time student of mindfulness meditation and serves on the Board of Directors and faculty of the Institute for Meditation and Psychotherapy. He teaches internationally about the application of mindfulness practice in psychotherapy and other fields, and maintains a private clinical practice in Lincoln, Massachusetts.

Dr. Siegel is author of a new book, The Extraordinary Gift of Being Ordinary: Finding Happiness Right Where You Are and of a comprehensive guide for general audiences, The Mindfulness Solution: Everyday Practices for Everyday Problems; coeditor of the critically acclaimed texts, Mindfulness and Psychotherapy, 2nd Edition and of Wisdom and Compassion in Psychotherapy; coauthor of the professional guide Sitting Together: Essential Skills for Mindfulness-Based Psychotherapy and of the self-treatment guide Back Sense, which integrates Western and Eastern approaches for treating chronic back pain. He is also professor for The Science of Mindfulness: A Research-Based Path to Well-Being produced by The Great Courses.

Dr. Siegel serves as a mentor in the CIIS program in psychedelic-assisted psychotherapy and is co-director of the annual Harvard Medical School Conferences on Meditation and Psychotherapy and Psychedelic-Assisted Psychotherapy.

Support psychedelic research and therapy development

By donating to Mind Medicine Australia, you will be helping us to accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation.

Disclaimer

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.